Health Psychology Research最新文献

{"title":"Cannabinoids and Their Role in Chronic Pain Treatment: Current Concepts and a Comprehensive Review.","authors":"Islam Shehata, Ahmed Hashim, Ahmed Elsaeidy, Anagha Nair, Ivan Urits, Omar Viswanath, Alan D Kaye, Marian Habib","doi":"10.52965/001c.35848","DOIUrl":"10.52965/001c.35848","url":null,"abstract":"<p><p>For decades, chronic pain was managed with an almost conventional approach of using a wide range of analgesic spectrum, surgical approaches and complex interventional pain techniques to modulate or even interrupt pain pathways. These different approaches carry many pharmacological hazards together with the lack of efficacy and safety of many interventional and surgical management techniques for chronic pain have mandated searching for other effective therapies including alternative treatments. Cannabinoids are naturally occurring substances that are derived from Cannabis sativa L. The usage of cannabinoids and their related synthetic chemical compounds has emerged as a choice in the management of different chronic pain conditions is being evaluated, however, the efficacy is still not consistently established. In the present investigation, therefore, we discuss the different aspects related to cannabinoids and their implications in the management of chronic pain conditions. This review will also discuss the safety profile of the cannabinoids together with the legal considerations that hinder their use in different countries.</p>","PeriodicalId":51865,"journal":{"name":"Health Psychology Research","volume":"10 4","pages":"35848"},"PeriodicalIF":2.0,"publicationDate":"2022-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820704/pdf/healthpsychologyresearch_2022_10_4_35848.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10520973","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Gender Dysphoria and Its Non-Surgical and Surgical Treatments.","authors":"Danyon Anderson,&nbsp;Himasa Wijetunge,&nbsp;Peyton Moore,&nbsp;Daniel Provenzano,&nbsp;Nathan Li,&nbsp;Jamal Hasoon,&nbsp;Omar Viswanath,&nbsp;Alan D Kaye,&nbsp;Ivan Urits","doi":"10.52965/001c.38358","DOIUrl":"https://doi.org/10.52965/001c.38358","url":null,"abstract":"<p><p>Gender dysphoria is defined by severe or persistent distress associated with an incongruence between one's gender identity and biological sex. It is estimated that 1.4 million Americans and 25 million people worldwide identify as transgender and that 0.6% of Americans experience gender dysphoria. The pathophysiology of gender dysphoria is multifactorial and incompletely understood. Genetics, androgen exposure, neuroanatomy, brain connectivity, history of trauma, parents with psychological disorders, and being raised by less than two parents are associated with gender dysphoria. Gender dysphoria most frequently presents in early teenage years but can present earlier or later. Anxiety and depression are the two most common comorbid diagnoses and may be the reason for presentation to medical care. Diagnosis is established through history and or validated questionnaires. Treatment includes psychosocial therapy, pharmacotherapy for underlying depression and/or anxiety, hormonal therapy, non-genital and/or genital feminization or masculinization operations. The frequency and severity of treatment related morbidity increases progressively as treatments go from conservative to more invasive. Gender dysphoria and its treatment is individualized and not completely understood.</p>","PeriodicalId":51865,"journal":{"name":"Health Psychology Research","volume":" ","pages":"38358"},"PeriodicalIF":2.0,"publicationDate":"2022-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501960/pdf/healthpsychologyresearch_2022_10_3_38358.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40379288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Viloxazine for the Treatment of Attention Deficit Hyperactivity Disorder.","authors":"Christopher L Robinson,&nbsp;Katelyn Parker,&nbsp;Saurabh Kataria,&nbsp;Evan Downs,&nbsp;Rajesh Supra,&nbsp;Alan D Kaye,&nbsp;Omar Viswanath,&nbsp;Ivan Urits","doi":"10.52965/001c.38360","DOIUrl":"https://doi.org/10.52965/001c.38360","url":null,"abstract":"<p><strong>Purpose of review: </strong>Attention deficit hyperactivity disorder (ADHD) is a widely diagnosed neurodevelopmental disorder giving rise to symptoms of hyperactivity, impulsivity, and inattentiveness that can impair daily functioning. Stimulants, such as methylphenidate and amphetamines, are the mainstay of treatment for ADHD. However, nonstimulant drugs such as viloxazine, atomoxetine, guanfacine, and clonidine are becoming more popular due to minimal adverse effects when compared to stimulants.</p><p><strong>Recent findings: </strong>Viloxazine is a selective norepinephrine reuptake inhibitor (NRI) originally used to treat depression in adults with activity in both the noradrenergic as well as serotonergic pathways. Studies have demonstrated its efficacy for its use in the treatment of ADHD. Unlike stimulants, viloxazine has a decreased chance of substance abuse, drug dependance, and withdrawal symptoms upon the cessation of therapy. Additionally, dopamine levels in the nucleus accumbens after treatment with viloxazine are elevated considerably less in comparison with traditional stimulant ADHD treatments. Viloxazine provides an alternative, nonstimulant approach to treating ADHD.</p><p><strong>Summary: </strong>Viloxazine is a recently approved, non-stimulant medication functions by inhibiting the uptake of norepinephrine which has been seen to be decreased in patients with ADHD. When patients do not respond to first-line stimulants, cannot tolerate the side effects, or have contraindications to stimulants, viloxazine may be a nonstimulant option offering patients an increasing arsenal of medications to treat ADHD.</p>","PeriodicalId":51865,"journal":{"name":"Health Psychology Research","volume":" ","pages":"38360"},"PeriodicalIF":2.0,"publicationDate":"2022-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501833/pdf/healthpsychologyresearch_2022_10_3_38360.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40379290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Mental Health in Non-Oncologic Urology Patients.","authors":"Danyon Anderson,&nbsp;Devesh Kumar,&nbsp;Divya Divya,&nbsp;Jose L Zepeda,&nbsp;Abrahim N Razzak,&nbsp;Jamal Hasoon,&nbsp;Omar Viswanath,&nbsp;Alan D Kaye,&nbsp;Ivan Urits","doi":"10.52965/001c.38352","DOIUrl":"https://doi.org/10.52965/001c.38352","url":null,"abstract":"<p><p>This article is a literature review of mental health concerns in non-oncologic urology patients. Pathologies represented in this review include Peyronie's Disease (PD), erectile dysfunction (ED), urinary incontinence and urinary tract infections (UTI), infertility, benign prostatic hyperplasia (BPH), kidney stones, and urinary retention. While there has been great interventional focus as of late for urogenitary malignancies (i.e. prostate cancer awareness with the Movember campaign), literature studies and intervention focused on non-oncologic urology patients has been limited. As such, we conducted a review on urology patients with non-oncologic pathologies as an effort to increase clinician awareness of mental health concerns among such patients, increase the comfort level for clinician communication on socially sensitive topics surrounding pathologies, and review ongoing interventions conducted within these pathologies. We outlined different ongoing Mental Health Illness (MHI) needs and treatments for various pathologies. Patients with non-cancerous urologic pathologies had lower quality of life and higher incidence of MHI than the general population. As such, in line with the American Urological Association recommendations, psychological and social support from peers, therapists, and healthcare providers further prove to be crucial for some subpopulations. The review also yielded pathology specific interventions such as group therapy for ED patients. Given the higher incidence of MHI in the patient population after the Covid-19 pandemic, MHI awareness in the sphere of non-oncologic urology treatment continues to be crucial when creating a collaborative treatment platform for patients.</p>","PeriodicalId":51865,"journal":{"name":"Health Psychology Research","volume":" ","pages":"38352"},"PeriodicalIF":2.0,"publicationDate":"2022-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501847/pdf/healthpsychologyresearch_2022_10_3_38352.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40379291","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Patient's Perception of Diabetes Care Services in Hail, Kingdom of Saudi Arabia.","authors":"Ramaiah Itumalla,&nbsp;Rakesh Kumar,&nbsp;Bilesha Perera,&nbsp;Mohamed Tharwat Elabbasy,&nbsp;Shashi Kumar Cg,&nbsp;Ramadevi Kundur","doi":"10.52965/001c.38119","DOIUrl":"https://doi.org/10.52965/001c.38119","url":null,"abstract":"<p><p>Globally, 643 million people will be affected by 2030, and 783 million by 2045 with diabetes mellitus (DM), a severe disease that affects 537 million people worldwide in 2021. Kingdom of Saudi Arabia (KSA) has the highest prevalence of diabetes mellitus among the top ten countries worldwide. Therefore, the present study aimed to identify the factors influencing diabetes care and assess their relative importance. Research was conducted in the Hail region of the Kingdom of Saudi Arabia. The study recruited 258 diabetes patients visiting the Primary Health Centers in Hail City as part of their routine healthcare. Analyzing the data was performed using the Statistical Package for Social Sciences (SPSS-22). As far as Cronbach's Alpha is concerned, it was 0.717, and Kaiser-Meyer-Olkin (KMO) was 0.705. The study has found that the six factors including accessibility of diabetes care (p = .024), availability of diabetes services (p = .029), quality of diabetes care (p = .024), disease management strategies (p = .037), basic amenities of health system (p = .028) and health education resources (p = .030) play a significant role in providing diabetes care services to patients. According to the adjusted R² of 0.773 (p 0.001), diabetes care is significantly influenced by these six variables. The comparative importance of the factors indicates that, out of six, quality of diabetes care is the most influential; the availability of diabetes services and health education resources are the second and third most influential factors. In order to provide better care for diabetic patients, healthcare organizations should focus on these factors.</p>","PeriodicalId":51865,"journal":{"name":"Health Psychology Research","volume":" ","pages":"38119"},"PeriodicalIF":2.0,"publicationDate":"2022-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502109/pdf/healthpsychologyresearch_2022_10_3_38119.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40379289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Methamphetamine Use: A Narrative Review of Adverse Effects and Related Toxicities.","authors":"Amber N Edinoff,&nbsp;Sarah E Kaufman,&nbsp;Keionne M Green,&nbsp;Daniel A Provenzano,&nbsp;Jesse Lawson,&nbsp;Elyse M Cornett,&nbsp;Kevin S Murnane,&nbsp;Adam M Kaye,&nbsp;Alan D Kaye","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Methamphetamine has been labeled \"America's most dangerous drug\" and has received significant public health attention. Stimulant addiction and tolerance are heavily documented in the literature; increasingly larger doses maintain euphoria in short time periods to withstand stimulant tolerance. Stimulant deaths are high in the United States and abroad. Between 2013 and 2019, deaths related to methamphetamine use quadrupled from 3,616 to 16,127. Methamphetamine use increased four-fold from 2015 to 2016. Due to this increase in methamphetamine use and its associated medical complications, the mortality rate associated with methamphetamine use has doubled over the past ten years. Cardiopulmonary symptoms include chest pain, palpitations, and shortness of breath. Methamphetamine-related myocardial infarction can also occur. Central nervous system symptoms include agitation, anxiety, delusions, hallucinations, and seizures. Methamphetamine-induced psychosis may unmask underlying psychiatric disorders. It can also cause cerebral vasculitis, which elicits cortical blindness and ischemic strokes. Methamphetamine-induced neurotoxicity in serotonergic systems is more diffuse, involving the striatum, hippocampus, septum, amygdala, and hypothalamus leading to mood changes, psychosis, and memory impairment. This narrative review will aim to highlight the adverse effects as well as the toxicity that can occur with methamphetamine use.</p>","PeriodicalId":51865,"journal":{"name":"Health Psychology Research","volume":" ","pages":"38161"},"PeriodicalIF":2.0,"publicationDate":"2022-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476235/pdf/healthpsychologyresearch_2022_10_3_38161.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40366595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Methamphetamine Use: A Narrative Review of Adverse Effects and Related Toxicities.","authors":"Amber N. Edinoff, S. Kaufman, Keionne M Green, Daniel A. Provenzano, Jesse Lawson, E. Cornett, K. Murnane, A. Kaye, A. Kaye","doi":"10.52965/001c.38161","DOIUrl":"https://doi.org/10.52965/001c.38161","url":null,"abstract":"Methamphetamine has been labeled \"America's most dangerous drug\" and has received significant public health attention. Stimulant addiction and tolerance are heavily documented in the literature; increasingly larger doses maintain euphoria in short time periods to withstand stimulant tolerance. Stimulant deaths are high in the United States and abroad. Between 2013 and 2019, deaths related to methamphetamine use quadrupled from 3,616 to 16,127. Methamphetamine use increased four-fold from 2015 to 2016. Due to this increase in methamphetamine use and its associated medical complications, the mortality rate associated with methamphetamine use has doubled over the past ten years. Cardiopulmonary symptoms include chest pain, palpitations, and shortness of breath. Methamphetamine-related myocardial infarction can also occur. Central nervous system symptoms include agitation, anxiety, delusions, hallucinations, and seizures. Methamphetamine-induced psychosis may unmask underlying psychiatric disorders. It can also cause cerebral vasculitis, which elicits cortical blindness and ischemic strokes. Methamphetamine-induced neurotoxicity in serotonergic systems is more diffuse, involving the striatum, hippocampus, septum, amygdala, and hypothalamus leading to mood changes, psychosis, and memory impairment. This narrative review will aim to highlight the adverse effects as well as the toxicity that can occur with methamphetamine use.","PeriodicalId":51865,"journal":{"name":"Health Psychology Research","volume":"17 1","pages":"38161"},"PeriodicalIF":2.0,"publicationDate":"2022-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85018712","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Ketamine-Induced Cystitis: A Comprehensive Review of the Urologic Effects of This Psychoactive Drug.","authors":"Danyon J Anderson,&nbsp;Jessica Zhou,&nbsp;David Cao,&nbsp;Matthew McDonald,&nbsp;Maya Guenther,&nbsp;Jamal Hasoon,&nbsp;Omar Viswanath,&nbsp;Alan D Kaye,&nbsp;Ivan Urits","doi":"10.52965/001c.38247","DOIUrl":"https://doi.org/10.52965/001c.38247","url":null,"abstract":"<p><p>Ketamine is a common medical anesthetic and analgesic but is becoming more widely used as a recreational drug. Significant side effects on the urinary tract are associated with frequent recreational ketamine use most notably ketamine-induced cystitis (KIC). Regular ketamine consumption has been shown to increase the risk of cystitis symptoms by 3- to 4-fold, and cessation of ketamine use is usually associated with improvement of symptoms. Common KIC-related problems are urinary pain and discomfort, bladder epithelial barrier damage, reduced bladder storage and increased pressure, ureter stenosis, and kidney failure, all of which significantly impact patients' quality of life. Furthermore, it becomes a vicious cycle when KIC patients attempt to manage their urinary pain with increased ketamine use. The precise pathophysiology of KIC is still unknown but several theories exist, most of which highlight the inflammatory signaling pathways leading to bladder epithelium damage due to presence of ketamine in the urine. Empirical treatment options for KIC are available and consist of ketamine cessation, noninvasive therapies, and surgery, and should be decided upon based on the time course and severity of the disease. Of note, cessation of use is strongly recommended for all KIC patients, and should be supplemented with motivational interviews and psychological and social support. It is crucial for clinicians to be familiar with KIC diagnosis and treatment, and to be prepared to have informed discussions with ketamine-using patients about the potential health consequences of ketamine.</p>","PeriodicalId":51865,"journal":{"name":"Health Psychology Research","volume":" ","pages":"38247"},"PeriodicalIF":2.0,"publicationDate":"2022-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476224/pdf/healthpsychologyresearch_2022_10_3_38247.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40366596","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Opioids in Urology: How Well Are We Preventing Opioid Dependence and How Can We Do Better?","authors":"Danyon J Anderson,&nbsp;David Y Cao,&nbsp;Jessica Zhou,&nbsp;Matthew McDonald,&nbsp;Abrahim N Razzak,&nbsp;Jamal Hasoon,&nbsp;Omar Viswanath,&nbsp;Alan D Kaye,&nbsp;Ivan Urits","doi":"10.52965/001c.38243","DOIUrl":"https://doi.org/10.52965/001c.38243","url":null,"abstract":"<p><p>Urologic procedures (both open and minimally invasive) can cause pain due to the surgery itself, devices placed, and post-operative issues. Thus, pain management is important for every post-procedure recovery period. Opioid use post-surgery is common and often over-prescribed contributing to persistent use by patients. In this article, we review the extent of opioid use in pediatric urologic procedures, vasectomy, endourologic procedures, penile implantation, urogynecologic procedures, prostatectomy, nephrectomy, cystectomy, and scrotal/testicular cancer surgery. Generally, we have found that institutions do not have a standardized protocol with a set regimen to prescribe opioids, resulting in more opioids being prescribed than needed and patients not properly disposing of their unused prescriptions. However, many institutions recognize their opioid overuse and are implementing new multimodal opioid-sparing analgesics methods such as non-opioid peri-operative medications, minimally invasive robotic surgery, and nerve blocks or local anesthetics with varying degrees of success. By shedding light on these opioid-free methods and prescription protocols, along with improved patient education and counselling, we hope to bring awareness to institutions and decrease unnecessary opioid use.</p>","PeriodicalId":51865,"journal":{"name":"Health Psychology Research","volume":" ","pages":"38243"},"PeriodicalIF":2.0,"publicationDate":"2022-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476236/pdf/healthpsychologyresearch_2022_10_3_38243.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40366598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Vasectomy Regret or Lack Thereof.","authors":"Danyon J Anderson,&nbsp;Morgan Lucero,&nbsp;Stephen Vining,&nbsp;Charles Daniel,&nbsp;Jamal Hasoon,&nbsp;Omar Viswanath,&nbsp;Alan D Kaye,&nbsp;Ivan Urits","doi":"10.52965/001c.38241","DOIUrl":"10.52965/001c.38241","url":null,"abstract":"<p><strong>Background: </strong>Vasectomy is a procedure that results in permanent yet reversible sterility and remains a great contraceptive option for many. Previous research studies have highlighted frequency of vasectomy utilization, defining characteristics of individuals who opt for this method, various surgical techniques, and the risks and benefits associated with the procedure. What remains to be defined is why or why not individuals may experience post-vasectomy regret and whether the previous characteristics correlate.</p><p><strong>Objective: </strong>The objective of this review is to synthesize information regarding reasons individuals may regret their vasectomy and seek reversal, what options exist for accomplishing the reversal, and patients' fertility prognosis post-vasovasostomy.</p><p><strong>Methods: </strong>This review utilized a combination of secondary and tertiary data analysis across a wide scope of academic databases pertaining to the topic of interest.</p><p><strong>Results: </strong>Typically, most males who have sought a vasectomy are satisfied with their decision, however, approximately 6% of this population seeks reversal. Key factors influencing vasectomy regret include age at the time of vasectomy, parental status, pre- and post-operative relationship status, unresolved physical and psychosexual problems, and development of chronic scrotal pain following the procedure. Few options exist for vasectomy reversal including microsurgical reconstructive vasectomy reversal (VR) and sperm extraction for in vitro fertilization. There is no guarantee that fertility will be restored in any case but a major predictive factor for success is the time interval prior to reversal.</p><p><strong>Conclusion: </strong>Vasectomy is intended to be a permanent form of contraception; however, a minor chance remains that individuals may experience post-operative regret due to various factors. This warrants proper comprehensive counseling by the patient's provider regarding benefits and risks, procedural outcomes, opportunities for reversal, and fertility prognosis.</p>","PeriodicalId":51865,"journal":{"name":"Health Psychology Research","volume":" ","pages":"38241"},"PeriodicalIF":2.0,"publicationDate":"2022-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476225/pdf/healthpsychologyresearch_2022_10_3_38241.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40367752","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}